| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/12/2002 | US6346278 Lipid extract of perna or mytilus |
| 02/12/2002 | US6346275 Drugs for immunology residues of corallinaceae, seaweed derivatives |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | WO2002010405A2 A human disintegrin protein |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010371A1 Novel physiologically active peptide and use thereof |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010351A2 Autologous connective tissues, methods for the production thereof and their use |
| 02/07/2002 | WO2002010348A2 Tissue implant for cartilage repair |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 02/07/2002 | WO2002010166A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010161A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002010136A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | WO2002009644A2 Angiogenic and osteogenic proteins for use in enhancing bone density and formation |
| 02/07/2002 | WO2002009637A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/07/2002 | WO2002009631A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | WO2001081310A8 1-aroyl-piperidinyl benzamidines |
| 02/07/2002 | WO2001074823A3 Fused heterocyclic derivatives, their production and use |
| 02/07/2002 | WO2001074811A3 Substituted 1,3-thiazole compounds, their production and use |
| 02/07/2002 | WO2001074380A3 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 02/07/2002 | WO2001070130A3 Compositions derived from modiolus modiolus and methods for making and using same |
| 02/07/2002 | WO2001060806A3 Substituted arylpyrazines |
| 02/07/2002 | WO2001044294A3 Compositions and methods for inhibiting endothelial cell proliferation |
| 02/07/2002 | WO2000032578A8 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/07/2002 | US20020016616 Electro-medical device for use with biologics |
| 02/07/2002 | US20020016471 Inhibitors of p38 |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016362 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016329 Inhibit p34cdc2/cyclin Bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example chemotherapy of tumours or osteoporosis. |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015735 Oral administering |
| 02/07/2002 | US20020015733 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 02/07/2002 | CA2417688A1 Tissue implant for cartilage repair |
| 02/07/2002 | CA2417650A1 Indazole derivatives as jnk inhibitors and compositions and methods related thereto |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417444A1 Nonsteroidal inflammation inhibitors |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417259A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | CA2417254A1 N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | CA2417204A1 Imidazolyl derivatives |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2417059A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416122A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | CA2415851A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | CA2415436A1 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | CA2415433A1 A human disintegrin protein |
| 02/07/2002 | CA2319694A1 Compound |
| 02/06/2002 | EP1177795A2 Use of ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 02/06/2002 | EP1177312A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 02/06/2002 | EP1177297A2 Novel nucleic acids and proteins with growth hormone activity |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177291A2 Laminin 8 and methods for its use |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/06/2002 | EP1177181A1 Substituted bicyclic compounds |
| 02/06/2002 | EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 02/06/2002 | EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1176985A2 Enzymatically activated polymeric drug conjugates |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176975A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 02/06/2002 | EP1176972A1 Use of phyllanthus for targeted stimulation of the immune system |
| 02/06/2002 | EP1176971A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 02/06/2002 | EP1176967A1 Management of pain after joint surgery |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP1176870A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 02/06/2002 | EP1021200B1 Methods and compositions for treating rheumatoid arthritis |
| 02/06/2002 | EP0971917B1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 02/06/2002 | EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334830A Hydrophilic ampholytic polymer |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334815A Methotrexate derivatives |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334809A Nonsteroidal antiinflammatories |
| 02/06/2002 | CN1334807A 1-heterocycle substd. diarylamines |
| 02/06/2002 | CN1334802A Ligands of nuclear receptor |
| 02/06/2002 | CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/06/2002 | CN1334800A 3,4,5-trisubstd. aryl nitrone compounds and pharmaceutical compositions contg. same |
| 02/06/2002 | CN1334740A Method for providing nutraceutical or phytoceutical benefits and inhibiting oxidation using cherry derivatives |